Currently I am a member of the Neuromorphic Speech Processing Lab at the Center for Biomedical Technology. Since 2011 have also been the Scientific-Technical Director of Glottex VAS SL, a company devoted to develop biomedical solutions to speech and hearing, and the monitoring and evaluation of neurodegenerative illnessess as Parkinson's Disease, Alzheimer's Disease, Lateral and Multiple Sclerosis, and others, as depression or dementia. I am promoting a Neurolinguistics Mindfulness Network to engage researchers and speech therapists in clinical applications of language production and perception.